Project Grant R01AI195448
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 26, 2026, with completion targeted for October 31, 2028. The award supports investigator-initiated biomedical research examining the pathogenic mechanisms underlying food allergen absorption and anaphylaxis risk....
- Federal Grant Award Summary Northwestern University received a $200,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 4, 2025, with a completion date of August 31, 2027. The award supports biomedical research focused on identifying and validating microRNAs (miRNAs) that regulate neutrophil transendothelial migration (TEM) in gut inflammation. The research...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $106,922 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 9, 2026, through September 8, 2028. The award funds investigator-initiated biomedical research examining the metabolic regulation of regulatory T cells (Tregs) through fatty acid metabolism during viral pneumonia. The...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $739,353 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026, through January 31, 2031. This award funds investigator-initiated biomedical research examining the structural and molecular mechanisms of CRAC (Calcium Release-Activated Calcium) channels, which...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $440,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 5, 2026, with a completion date of January 31, 2028. The research initiative investigates neutrophil priming as a method to train macrophage functional memory, with the objective of developing therapeutic strategies...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Ann & Robert H Lurie Children's Hospital of Chicago a $1,530,922 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 10, 2025, for the refinement and validation of a symptom report-based food allergy (FA) prevalence questionnaire for population-based studies. The project, extending through August 31, 2029, addresses the critical gap in...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $250,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 21, 2025, with a completion date of July 31, 2026. The award supports the development of a novel synthetic immunological niche (IN) scaffold technology designed to analyze and predict immune response heterogeneity in food allergies. The research...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $440,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 10, 2026, with completion targeted for January 31, 2028. The award funds research to develop engineered supramolecular peptide amphiphile (PA) nanofibers that display both fibroblast growth factor-2 (FGF-2) mimetic and...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $151,040 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 1, 2026, through December 31, 2027. The grant supports investigator-initiated biomedical research focused on elucidating the mechanisms controlling Neisseria gonorrhoeae Type IV Pilus (T4P) dynamics and...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $431,784 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research on Pseudomonas aeruginosa (PA) gastrointestinal carriage mechanisms. The award, obligated on February 19, 2026, with a completion date of January 31, 2028, supports research utilizing an...
Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $493,889 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective April 1, 2026, through March 31, 2031. This award supports investigator-initiated biomedical research aimed at elucidating the mechanisms underlying food-specific immunoglobulin E (IgE) antibody induction in the gastrointestinal tract—a critical knowledge gap given that more than 32 million Americans are affected by food allergies. The research employs mouse models of oral peanut exposure combined with advanced immunological techniques to identify environmental triggers and cellular pathways responsible for pathogenic food-specific IgE production. The research deliverables include identification of pro-allergenic invariant natural killer T (iNKT) cell subsets, characterization of their interaction with type 2 conventional dendritic cells and T follicular helper cells, and elucidation of the cytokine and co-stimulatory signals driving food-specific IgE production. Additionally, the project will test alternative lipid-based mechanisms that may promote food-specific IgE through iNKT and other lipid-restricted T cell pathways. These scientific outputs are intended to advance understanding of food allergy pathogenesis and potentially identify therapeutic targets for prevention and treatment of food allergic responses.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $493.9k | 3/27/26 |